Showing results (491-500 of 502) with videos related to
Sort By:
Pageof 51
BJOG : an International Journal of Obstetrics and Gynaecology|May 22, 2018
Routine antenatal ultrasound in low- and middle-income countries: first look - a cluster randomised trialR L Goldenberg, R O Nathan, D Swanson, et al.Biorxiv : the Preprint Server for Biology|July 14, 2025
Sialylated CD43 is a glyco-immune checkpoint for macrophage phagocytosisJooho Chung, Mounica Vallurupalli, Sarah Noel, et al.Nature Genetics|June 9, 2026
Inflammatory cytokines induce new cancer dependenciesCollins K Cheruiyot, Sarah Y Kim, Juan Dubrot, et al.JCI Insight|April 30, 2024
Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccineLeetah Senkpeil, Jyoti Bhardwaj, Morgan R Little, et al.Science (New York, N.Y.)|July 11, 2024
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunityMeng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula, et al.Nature Immunology|September 23, 2022
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancerJuan Dubrot, Peter P Du, Sarah Kate Lane-Reticker, et al.Science (New York, N.Y.)|April 9, 2026
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunityJooho Chung, Mounica Vallurupalli, Sarah Noel, et al.Immunity|November 19, 2024
Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpointHsiao-Wei Tsao, Seth Anderson, Kenneth J Finn, et al.Nucleic Acids Research|December 21, 2004
The Biomolecular Interaction Network Database and related tools 2005 updateC Alfarano, C E Andrade, K Anthony, et al.Nature|January 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapyYi Sun, Or-Yam Revach, Seth Anderson, et al.Pageof 51